Sign in
DRTSW Stock Price, Chart, Stats & News
Alpha Tau Medical Ltd.
Save
883.39M
Market cap
–
Current P/E
–
Forward P/E
DRTSW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.32% |
ROA | -40.00% |
ROE | -57.29% |
D/E | 0.18x |
Interest coverage ratio | – |
DRTSW valuation
P/E | – |
P/S | – |
P/B | 7.62x |
P/CF | -22.03x |
P/FCF | -18.43x |
P/OCF | -22.03x |
PEG | -0.14x |
EV multiple | -14.59x |
About
Alpha Tau Medical Ltd. is a clinical-stage biopharmaceutical company dedicated to the research, development, and eventual commercialization of innovative cancer treatments. Its primary focus is on Alpha DaRT (diffusing alpha-emitters radiation therapy), a novel approach designed to effectively treat solid tumors. The company's initial commercialization efforts are concentrated in Israel and the United States.
Similar securities
Based on sector and market capitalization
Report issue